Delirium, Dementia, Amnestic, Cognitive Disorders  >>  rilapladib (SB-659032)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
rilapladib (SB-659032) / GSK
NCT02130661: Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers

Withdrawn
1
0
US
Rilapladib 25 mg, Rilapladib 250 mg, Itraconazole
GlaxoSmithKline
Alzheimer's Disease
01/18
01/18

Download Options